Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba and Piracetam for Post Covid-19 Syndrome
NCT07722000Completed
- Sponsor
- Beni Suef University
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Trial of ginkgo biloba extract and piracetam in Post COVID-19 Syndrome (PCS) (3 arms), sponsored by Beni Suef University. Primary endpoint: Mini-Mental State Examination at 1 year. Started Feb 2021; status: completed.
02
Drugs
ginkgo biloba extractpiracetam
03
Conditions
Post COVID-19 Syndrome (PCS)
Beyond the preview
Go deeper on NCT07722000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07722000.